United States · FDA National Drug Code directory
Atenolol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-022_860eb406-b330-4b72-b768-122d57c74293
- Product NDC
- 68382-022
- Form
- TABLET
- Composition / generic term
- Atenolol
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20051008
- Source listing expiry
- 20261231
Source-listed ingredients
- ATENOLOL — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-022-01) · 68382-022-01
- 1000 TABLET in 1 BOTTLE (68382-022-10) · 68382-022-10
- 90 TABLET in 1 BOTTLE (68382-022-16) · 68382-022-16
- 10000 TABLET in 1 BOTTLE (68382-022-24) · 68382-022-24
- 5000 TABLET in 1 BOTTLE (68382-022-40) · 68382-022-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →